Clinical Trial Update: Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and tolerability of CVGBM in adults with newly diagnosed MGMT-unmethylated glioblastoma or astrocytoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioblastoma

Drugs mentioned

• CVGBM

Snippet

Sponsor: CureVac | Conditions: Glioblastoma | Phase 1 | Status: COMPLETED